Atlas Trials

Live Microbials to Boost Anti-Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) Immunity Clinical Trial

Clinical trial NCT04847349 · COMPLETED

Trial details

NCT number
NCT04847349
Sponsor
Rutgers, The State University of New Jersey
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Covid19
Start date
2021-04-13
Primary completion
2021-11-01
Enrollment
54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.